Hot Investor 1: VC/PE Investment Firm Backed by China and Taiwan Companies Invests Broadly Across Seed and Post-Seed Stage Life Science Companies

22 Mar

A venture capital and private equity firm based in Cambridge, MA provides seed capital out of an angel group subsidiary within the firm, and also provides equity to later stage IT (robotics, AI, IoT, new materials, FinTech, etc.) and healthcare companies. The firm is backed by five public pharmaceutical companies and ten public IT and healthcare companies from Taiwan and China. The angel group subsidiary provides up to $2M seed stage investments in early-stage companies, while the parent firm provides equity of $2M – $5M per company post seed stage. The firm is also actively looking for PE and M&A opportunities worldwide in the $1B ~ 5B range. The firm seeks companies on a global level, though has a focus in Boston and North America East Coast-based companies.

Within healthcare, the firm is interested in biotech therapeutics, medical devices, healthcare IT and digital health. The firm is opportunistic in subsector and indication and has a specific interest in oncology products. For healthcare IT, the firm is interested in software, AI, robotics, and digital health technology that seeks to integrate into hospital systems. For medical devices, the firm is interested in drug delivery system devices that require a therapeutic component. The firm typically seeks companies that already have CE Mark, FDA, CFDA, or TFDA approval.

The firm requires the management team to have technical expertise in their field of study, and prefers companies that also have business development expertise. The firm typically takes a board seat after an investment, but at the minimum will maintain a close relationship with the entrepreneur as a support and advisor. The firm typically participates in two financing rounds per company, and also supports the company in finding add-on investors for the following round.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: